If you're looking for a platform that uses AI to identify new polymorphs with improved properties for pharmaceutical development, Lavo Life Sciences offers a powerful AI-accelerated crystal structure prediction system. This system helps drug development teams by optimizing solid-state formulations and discovering novel polymorphs. Using physically-constrained AI algorithms trained on large data sets, it can analyze millions of potential crystal structures in days, considering environmental factors like temperature and pressure. This can speed up the process and minimize the risk of late-stage surprises.
Another notable option is Genesis Therapeutics with their GEMS platform. While primarily focused on finding novel protein targets and unexplored chemical space, it combines deep learning and molecular simulations to predict properties and generate molecules. This platform is designed to help researchers design first- and best-in-class small molecule drugs with high potency and selectivity, which can be beneficial for pharmaceutical development by identifying promising compounds early on.